Skip to main content Skip to section navigation Skip to footer
Careers News & Media Contact
OPKO Health, Inc. OPKO Health, Inc.
  • Therapies
    • Overview
    • Ngenla
    • Rayaldee
  • Research
    • Overview
    • Pipeline
    • Publications
    • Scientific Presentations
  • Diagnostics
  • Company
    • Overview
    • Leadership
    • Locations
  • Partnerships
  • Investors
    • Overview
    • News / Events
    • Presentations
    • Company Info
    • Financial Info
    • Stock Data
    • SEC Filings
    • Governance
  • Careers
  • News & Media
  • Contact

Press Releases

News & Media

News & Media

  • Press Releases
  • Announcements
  • Events
  • Presentations
Nov 29, 2012 9:18am EST

OPKO Health Announces Research Grants from Mexican Technology and Science Council

Oct 01, 2012 9:12am EDT

OPKO Health Announces Launch of 4Kscore™ in Europe

Aug 22, 2012 3:16pm EDT

OPKO Health Awarded NASA Contract

Aug 03, 2012 6:00am EDT

OPKO Health Announces Acquisition of Growing European Healthcare Company

Jul 18, 2012 10:36am EDT

OPKO Health Announces License for Topically Active Formulation of Ranibizumab

Jul 17, 2012 9:20am EDT

OPKO Scientist Reports Results at Alzheimer’s Association International Conference

Jul 16, 2012 8:30am EDT

OPKO Health Announces Appointment of Juan F. Rodriguez as Chief Financial Officer

Jun 05, 2012 9:11am EDT

OPKO Health To Acquire Stake in Israeli Hepatitis B Vaccine Manufacturer

May 31, 2012 12:24pm EDT

OPKO Health to Present at the Jefferies 2012 Global Healthcare Conference

May 31, 2012 10:06am EDT

OPKO Health Receives Core Technology U.S. Patent Allowance

  • Previous Pagearrow_back
  • Page 1
  • …
  • Page 38
  • Page 39
  • Page 40
  • Page 41
  • Page 42
  • Page 43
  • Page 44
  • Page 45
  • Page 46
  • Page 47
  • …
  • Page 52
  • Next Pagearrow_forward
rss_feed News RSS

OPKO Health, Inc.
4400 Biscayne Boulevard
Miami, FL 33137


T: 305-575-4100
contact@opko.com

©2025 OPKO Health, Inc. All Rights Reserved.
Privacy Policy Governance Terms of use Sitemap